We use cookies to make this site as useful as possible. By continuing browsing we assume that you agree to accept cookies in accordance with our cookie policy.
To find out more or to change your cookie settings at any time, see our cookie policy. OK

  • Products
  • Therapy Areas
  • Dechra Businesses
  • Contact us
  • Select country
    • Danmark
    • Suomi
    • France
    • Deutschland
    • Österreich
    • Nederland
    • Norge
    • Ireland
    • Italia
    • España
    • Portugal
    • Sverige
    • United Kingdom
    • België
    • USA
    • Canada
    • Polska
    • Hrvatska
    • Bosna i Hercegovina
    • Slovenija
    • Australia
    • México
    • Global
    • By clicking a flag you will be leaving this country website to access another site in the Dechra group not applicable to your territory and which may have different legislation
Dechra
  • About
  • Investor Relations
  • Corporate Governance
  • Careers
  • Sustainability
  • You are here:
  • Home
  • / Corporate Governance
  • / Director Shareholding
  • Back
  • You are here:
  • Director Shareholding
  • Directors' Remuneration Policy
  • Articles of Association
  • Terms of Reference
  • Director Shareholding

Director Shareholding

The beneficial interests of the Directors in office and their families in the share capital of Dechra Pharmaceuticals PLC are as follows:

Director As at 8 October 2020  
  Number of Ordinary Shares Percentage of issued share capital
Tony Rice 20,000 0.019%
Ian Page 638,919 0.591%
Paul Sandland 6,518 0.006%
Tony Griffin 70,650 0.065%
Lisa Bright 788 0.001%
Julian Heslop 6,000 0.006%
Lawson Macartney 5,880 0.005%
Ishbel Macpherson 5,848 0.005%
Alison Platt 760 0.001%
 
 
 
 
 
 
 
 
 
 
 
 

Navigation

  • Directors' Remuneration Policy
  • Articles of Association
  • Terms of Reference
  • Director Shareholding
Website: Co3
  • Modern Slavery Statement
  • Terms of Use
  • Privacy Notice
  • Cookie Policy
  • Sitemap

Sign in

Sign in

Help: Forgot password?